Expt. | Mass Spec Type* | Experiment Description | Quantitative Technique | Mass Spectrometry Filter Used | Reference** |
---|
1 | MALDI-TOF | IMCD vs. non-IMCD protein amounts | DIGE | p-value<0.1 | Hoffert, 2004 |
2 | MALDI-TOF | 3 day vasopresson infusion to Brattleboro rat | DIGE | p-value<0.1 | van Balkom, 2004 |
3 | LC-MS/MS (LCQ) | IMCD vs. non-IMCD protein amounts | ICAT | 2 or more peptides match | Pisitkun, 2006 |
4 | LC-MS/MS (LCQ) | 3 day vasopresson infusion to Brattleboro rat | ICAT | 2 or more peptides match | Pisitkun, 2006 |
5 | LC-MS/MS (LCQ) | Isolation of AQP-2 containing intracellular vesicles | none | 2 or more peptides match | Barile, 2005 |
6 | LC-MS/MS (LCQ) | Flow through proteins from avidin affinity step of technique 4 | none | 2 or more peptides match | Pisitkun, 2006 |
7 | MALDI-TOF/TOF | Vasopressin escape in rat | DIGE | p-value<0.1 | Hoorn, 2005 |
8 | LC-MS/MS (LTQ and FT-ICR) | Phosphoproteome of IMCD | Label free | 1 or more peptide + manual examination of FT-ICR data | Hoffert, 2006 |
9 | LC-MS/MS (LTQ) | IMCD vs. non-IMCD protein amounts | IVICAT | 2 or more peptides match | Simons, 2006 |
10 | LC-MS/MS (LTQ) | Perfusion-biotinylation or incubation-biotinylation of IMCD | none | 1 or more peptide + manual examination | Yu, 2006 |
10a | LC-MS/MS (LTQ) | Fixed perfusion-biotinylation | none | 1 or more peptide + manual examination | Yu, 2006 |
10b | LC-MS/MS (LTQ) | fixed incubation-biotinylation | none | 1 or more peptide + manual examination | Yu, 2006 |
10c | LC-MS/MS (LTQ) | 10a or 10b without fixation | none | 4 or more peptide + manual examination | Yu, 2006 |
11 | LC-MS/MS (LTQ) | Proteome of differential centrifugation fractions of rat IMCD | Label free | False discovery rate <2% by target-decoy analysis | Sachs, 2008 |
12 | LC-MS/MS (LTQ) | Proteome of nuclei from rat IMCD | none | False discovery rate <2% by target-decoy analysis | Tchapyjnikov, 2009 |
13 | LC-MS/MS (LTQ) | IMCD samples were treated with dDAVP for 30 min. | Label free | False discovery rate <2% by target-decoy analysis | Bansal, 2010 |
14 | LC-MS/MS (LTQ-Orbitrap XL) | Large-scale phosphotyrosine proteomic profiling | none | False discovery rate <1% by target-decoy analysis | Zhao, 2012 |
15 | LC-MS/MS (LTQ-Orbitrap Velos) | Phosphoproteomics of rat IMCD: response to vasopressin | iTRAQ | False discovery rate <1% by target-decoy analysis | Hoffert, 2012 |
16 | LC-MS/MS (LTQ-Orbitrap Velos) | Phosphoproteomics of rat IMCD: response to vasopressin antagonist satavaptan | iTRAQ | False discovery rate <1% by target-decoy analysis | Hoffert, 2014 |
17 | LC-MS/MS (LTQ-Orbitrap) | IMCD phosphoproteome after 9 hour lithium administration | Label free | False discovery rate <2% by target-decoy analysis | Trepiccione, 2014 |
18 | LC-MS/MS (LTQ-Orbitrap Velos) | In vitro phosphorylation of proteins in IMCD suspensions | Label free | False discovery rate <1% by target-decoy analysis | Bradford, 2014 |
19 | LC-MS/MS (LTQ-Orbitrap Velos) | Proteomic profiling of cellular fractions enriched in nuclear proteins from native IMCD cells | Label free | False discovery rate <1% by target-decoy analysis | Pickering, 2016 |
20 | LC-MS/MS (LTQ-Orbitrap Velos) | Proteomic profiling of cellular fractions enriched in cytoplasmic proteins from native IMCD cells | Label free | False discovery rate <1% by target-decoy analysis | LeMaire, 2016 |
**References